// App-Quantinova.ai

14972 : Timing, Profile, and Predictors of Spontaneous Myocardial Infarction Following a Non-ST-Segment Elevation Acute Coronary Syndrome Event: Insights From the TRILOGY-ACS Trial

Researchers

Presenter

  • Benjamin Neely

Principal Investigators

  • E. Magnus Ohman

  • Dorairaj Prabhakaran

  • Felipe Martinez

  • Jose C. Nicolau

  • Keith A. Fox

  • Paul W. Armstrong

  • Matthew T. Roe

  • Diego Ardissino

  • Azienda Ospedaliero

  • Christian Hamm

  • Shaun G. Goodman

  • Deepak L. Bhatt

  • Eileen B. Brown

  • Harvey D. White

Medical Centers

  • Duke Clinical Res Inst and Duke Univ Sch of Med, Durham, NC

  • Kerckhoff Heart Center, Bad Nauheim, Germany

  • The University of Edinburgh, Edinburgh, United Kingdom

  • Heart Institute - InCor, University of Sao Paulo Medical School, Sao Paulo, Brazil

  • Brigham and Women's Hospital and Harvard Medical School, Boston, MA

  • Green Lane Cardiovascular Service, Auckland City Hospital, Auckland, New Zealand

  • Duke Clinical Research Institute, Durham, NC

  • Cordoba Natl Univ, Cordoba, Argentina

  • Univ of Parma, Parma, Italy

  • St. Michael's Hosp, Toronto, ON, Canada

  • Edmonton, AB, Canada

  • Centre for Chronic Disease Control, New Delhi, India

Locations

  • Brazil

  • Canada

  • Argentina

  • Italy

  • Germany

  • United Kingdom

  • United States

  • India

  • New Zealand

Companies

  • Eli Lilly and Compan

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

Disease

  • Acute Coronary Syndromes

  • Myocardial infarction

  • Angina

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved